BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12374425)

  • 1. Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift.
    Schwartz M; Kipnis J
    Neuroscientist; 2002 Oct; 8(5):405-13. PubMed ID: 12374425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases.
    Schwartz M; Kipnis J
    J Neurol Sci; 2005 Jun; 233(1-2):163-6. PubMed ID: 15949502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic T cell-based vaccination for neurodegenerative disorders: the role of CD4+CD25+ regulatory T cells.
    Schwartz M; Kipnis J
    Ann N Y Acad Sci; 2005 Jun; 1051():701-8. PubMed ID: 16127010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.
    de Rosbo NK; Ben-Nun A
    J Autoimmun; 1998 Aug; 11(4):287-99. PubMed ID: 9776706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders.
    Kipnis J; Schwartz M
    Trends Mol Med; 2002 Jul; 8(7):319-23. PubMed ID: 12114110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity.
    Schwartz M; London A; Shechter R
    Neuroscience; 2009 Feb; 158(3):1133-42. PubMed ID: 19103265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation.
    Schwartz M; Baruch K
    J Autoimmun; 2014 Nov; 54():8-14. PubMed ID: 25199710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-specific therapies in multiple sclerosis.
    van Noort JM
    Biotherapy; 1998; 10(3):237-50. PubMed ID: 9559979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P; Raus J
    Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis.
    Hohlfeld R; Meinl E; Weber F; Zipp F; Schmidt S; Sotgiu S; Goebels N; Voltz R; Spuler S; Iglesias A
    Neurology; 1995 Jun; 45(6 Suppl 6):S33-8. PubMed ID: 7783909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological approaches to neuroprotection. boosting of protective autoimmunity.
    Schwartz M
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S256-60; discussion S273-6. PubMed ID: 11377445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune maintenance and neuroprotection of the central nervous system.
    Cohen IR; Schwartz M
    J Neuroimmunol; 1999 Dec; 100(1-2):111-4. PubMed ID: 10695721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the immune system for neuroprotection: therapeutic vaccines for acute and chronic neurodegenerative disorders.
    Schwartz M
    Cell Mol Neurobiol; 2001 Dec; 21(6):617-27. PubMed ID: 12043837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of multiple sclerosis.
    Olsson T
    Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):195-202. PubMed ID: 1623247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunology of multiple sclerosis: new intricacies and new insights.
    Ransohoff RM; Tuohy V; Lehmann P
    Curr Opin Neurol; 1994 Jun; 7(3):242-9. PubMed ID: 8081518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].
    Jaƛkiewicz E
    Postepy Hig Med Dosw (Online); 2004; 58():472-82. PubMed ID: 15765008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-based modulation of autoimmune responses in multiple sclerosis and experimental autoimmmune encephalomyelitis: therapeutic implications.
    Mastorodemos V; Ioannou M; Verginis P
    Neuroimmunomodulation; 2015; 22(3):181-95. PubMed ID: 24852748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients.
    Cassan C; Liblau RS
    J Neurochem; 2007 Feb; 100(4):883-92. PubMed ID: 17181557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective autoimmunity against the enemy within: fighting glutamate toxicity.
    Schwartz M; Shaked I; Fisher J; Mizrahi T; Schori H
    Trends Neurosci; 2003 Jun; 26(6):297-302. PubMed ID: 12798598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.